BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 11857064)

  • 1. A null mutation within the ciliary neurotrophic factor (CNTF)-gene: implications for susceptibility and disease severity in patients with multiple sclerosis.
    Hoffmann V; Pöhlau D; Przuntek H; Epplen JT; Hardt C
    Genes Immun; 2002 Feb; 3(1):53-5. PubMed ID: 11857064
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ciliary neurotrophic factor genotype does not influence clinical phenotype in amyotrophic lateral sclerosis.
    Al-Chalabi A; Scheffler MD; Smith BN; Parton MJ; Cudkowicz ME; Andersen PM; Hayden DL; Hansen VK; Turner MR; Shaw CE; Leigh PN; Brown RH
    Ann Neurol; 2003 Jul; 54(1):130-4. PubMed ID: 12838531
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ciliary neurotrophic factor null alleles are not a risk factor for Charcot-Marie-Tooth disease, hereditary neuropathy with pressure palsies and amyotrophic lateral sclerosis.
    Van Vught PW; Van Wijk J; Bradley TE; Plasmans D; Jakobs ME; Veldink JH; de Jong JM; Van den Berg LH; Baas F
    Neuromuscul Disord; 2007 Dec; 17(11-12):964-7. PubMed ID: 17651970
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of HLA-DRB1 alleles on susceptibility and outcome of a Portuguese Multiple Sclerosis population.
    Silva AM; Pereira C; Bettencourt A; Carvalho C; Couto AR; Leite MI; Marta M; Freijo M; Costa PP; Mendonça D; Monteiro L; Armas JB; Martins B
    J Neurol Sci; 2007 Jul; 258(1-2):69-74. PubMed ID: 17412364
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activation of the ciliary neurotrophic factor (CNTF) signalling pathway in cortical neurons of multiple sclerosis patients.
    Dutta R; McDonough J; Chang A; Swamy L; Siu A; Kidd GJ; Rudick R; Mirnics K; Trapp BD
    Brain; 2007 Oct; 130(Pt 10):2566-76. PubMed ID: 17898009
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HLA-DRB1*1501, -DQB1*0301, -DQB1*0302, -DQB1*0602, and -DQB1*0603 alleles are associated with more severe disease outcome on MRI in patients with multiple sclerosis.
    Zivadinov R; Uxa L; Bratina A; Bosco A; Srinivasaraghavan B; Minagar A; Ukmar M; Benedetto Sy; Zorzon M
    Int Rev Neurobiol; 2007; 79():521-35. PubMed ID: 17531857
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of a null mutation in the CNTF gene with early onset of multiple sclerosis.
    Giess R; Mäurer M; Linker R; Gold R; Warmuth-Metz M; Toyka KV; Sendtner M; Rieckmann P
    Arch Neurol; 2002 Mar; 59(3):407-9. PubMed ID: 11890844
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HLA-DRB1 associations with disease susceptibility and clinical course in Australians with multiple sclerosis.
    Stankovich J; Butzkueven H; Marriott M; Chapman C; Tubridy N; Tait BD; Varney MD; Taylor BV; Foote SJ; ; Kilpatrick TJ; Rubio JP
    Tissue Antigens; 2009 Jul; 74(1):17-21. PubMed ID: 19392788
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of the HLA-DRB1*15 allele group and the DRB1*1501 and DRB1*1503 alleles with multiple sclerosis in White and Mulatto samples from Brazil.
    Brum DG; Barreira AA; Louzada-Junior P; Mendes-Junior CT; Donadi EA
    J Neuroimmunol; 2007 Sep; 189(1-2):118-24. PubMed ID: 17681614
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HLA-DRB1 and multiple sclerosis in Malta.
    Dean G; Yeo TW; Goris A; Taylor CJ; Goodman RS; Elian M; Galea-Debono A; Aquilina A; Felice A; Vella M; Sawcer S; Compston DA
    Neurology; 2008 Jan; 70(2):101-5. PubMed ID: 18057318
    [TBL] [Abstract][Full Text] [Related]  

  • 11. No association between the CNTF null mutation and schizophrenia or personality.
    Nishiyama J; Tochigi M; Itoh S; Otowa T; Kato C; Umekage T; Kohda K; Ebisawa T; Kato N; Sasaki T
    Psychiatr Genet; 2006 Oct; 16(5):217-9. PubMed ID: 16969278
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epistasis between HLA-DRB1 parental alleles in a Spanish cohort with multiple sclerosis.
    Romero-Pinel L; Pujal JM; Martínez-Yélamos S; Gubieras L; Matas E; Bau L; Torrabadella M; Azqueta C; Arbizu T
    J Neurol Sci; 2010 Nov; 298(1-2):96-100. PubMed ID: 20810130
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Null mutation in human ciliary neurotrophic factor gene confers higher body mass index in males.
    O'Dell SD; Syddall HE; Sayer AA; Cooper C; Fall CH; Dennison EM; Phillips DI; Gaunt TR; Briggs PJ; Day IN
    Eur J Hum Genet; 2002 Nov; 10(11):749-52. PubMed ID: 12404108
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Heterogeneity at the HLA-DRB1 locus and risk for multiple sclerosis.
    Barcellos LF; Sawcer S; Ramsay PP; Baranzini SE; Thomson G; Briggs F; Cree BC; Begovich AB; Villoslada P; Montalban X; Uccelli A; Savettieri G; Lincoln RR; DeLoa C; Haines JL; Pericak-Vance MA; Compston A; Hauser SL; Oksenberg JR
    Hum Mol Genet; 2006 Sep; 15(18):2813-24. PubMed ID: 16905561
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The BDNF-Val66Met polymorphism: implications for susceptibility to multiple sclerosis and severity of disease.
    Lindquist S; Schott BH; Ban M; Compston DA; Sawcer S; Sailer M
    J Neuroimmunol; 2005 Oct; 167(1-2):183-5. PubMed ID: 16046000
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CNTF is a major protective factor in demyelinating CNS disease: a neurotrophic cytokine as modulator in neuroinflammation.
    Linker RA; Mäurer M; Gaupp S; Martini R; Holtmann B; Giess R; Rieckmann P; Lassmann H; Toyka KV; Sendtner M; Gold R
    Nat Med; 2002 Jun; 8(6):620-4. PubMed ID: 12042814
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CTLA-4 and multiple sclerosis: the A49G single nucleotide polymorphism shows no association with multiple sclerosis in a Southern Australian population.
    Wray BN; Stankovich J; Whittock L; Dwyer T; Ponsonby AL; van der Mei IA; Taylor B; Dickinson J; Foote S; McMorran BJ
    J Neuroimmunol; 2008 May; 196(1-2):139-42. PubMed ID: 18378005
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Deficiency of human ciliary neurotropic factor (CNTF) is not causally related to amyotrophic lateral sclerosis (ALS)].
    Takahashi R
    Rinsho Shinkeigaku; 1995 Dec; 35(12):1543-5. PubMed ID: 8752458
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HLA-DRB1*15 allele influences the later course of relapsing remitting multiple sclerosis.
    Cournu-Rebeix I; Génin E; Leray E; Babron MC; Cohen J; Gout C; Alizadeh M; Perdry H; Semana G; Brassat D; Clerget-Darpoux F; Yaouanq J; Edan G; Rosenheim M; Fontaine B
    Genes Immun; 2008 Sep; 9(6):570-4. PubMed ID: 18615093
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Parent-of-origin of HLA-DRB1*1501 and age of onset of multiple sclerosis.
    Ramagopalan SV; Byrnes JK; Dyment DA; Guimond C; Handunnetthi L; Disanto G; Yee IM; Ebers GC; Sadovnick AD
    J Hum Genet; 2009 Sep; 54(9):547-9. PubMed ID: 19629136
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.